Skip to content

Revenue at other companies

Henry Schein logo
Henry ScheinHSIC
$3.37B+6.3%
CSX logo
CSXCSX
$3.48B+1.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$246.09M+87.0%
SBA Communications logo
SBA CommunicationsSBAC
$47.29M-1.6%
Loar Holdings logo
Loar HoldingsLOAR
$9.7M+48.1%
Armstrong World Industries logo
Armstrong World IndustriesAWI
$382.9M+12.8%

Other financials

Income statement

See full
Revenue$574.8M+6.4%
Net income$171.0M+13.3%
EPS (diluted)$2.65+15.2%

Balance sheet

See full
Cash & equivalents$7.1B-9.0%
Total debt$296.4M
Total equity$4.5B+10.1%
Total assets$52.7B+1.4%

Cash flow

See full
Operating cash flow$237.3M+180%
CapEx$38.6M-5.7%
Free cash flow$198.7M+159%

Valuation

See full
Market cap$9.15B+7.3%
P/E13.7×-0.6×
P/S0.0×

Profitability

See full
Net margin29.5%+1.0pp
FCF margin3.5%

Returns & leverage

See full
Return on equity15.5%0.0pp
Debt / equity0.1×

Where this comes from

Reported directly by Cullen/Frost Bankers in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cullen/Frost Bankers’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cullen/Frost Bankers's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cullen/Frost Bankers's revenue?
Cullen/Frost Bankers (CFR) reported revenue of $32.16M in Q1 2026.
How has Cullen/Frost Bankers's revenue changed year-over-year?
Cullen/Frost Bankers's revenue increased by 12.4% year-over-year, from $28.62M to $32.16M.
What is the long-term trend for Cullen/Frost Bankers's revenue?
Over 4 years (2021 to 2025), Cullen/Frost Bankers's revenue has grown at a 9.9% compound annual growth rate (CAGR), from $83.29M to $121.57M.